The US Food and Drug Administration could authorize COVID-19 boosters from Pfizer Inc and BioNTech SE for use in 16- and 17-year olds as soon as next week, the Wall Street Journal reported late on Monday, citing a person familiar with the planning.
FDA moving to authorize Pfizer booster for 16-, 17-year-olds - report
By REUTERS
11/15/2024 01:15 AM
By REUTERS
11/15/2024 12:05 AM
By REUTERS
11/14/2024 11:50 PM
By REUTERS
11/14/2024 11:19 PM
By REUTERS
11/14/2024 10:50 PM
By REUTERS
11/14/2024 07:50 PM
By REUTERS
11/14/2024 06:46 PM
By REUTERS
11/14/2024 03:56 PM
By REUTERS
11/14/2024 03:55 PM
By REUTERS
11/14/2024 02:27 PM